instagram pinterest linkedin facebook twitter goodreads facebook circle twitter circle linkedin circle instagram circle goodreads circle pinterest circle

"Why do cancer drugs get such an easy ride?"

BMJ Easy Ride article (318 KB)

Rushed approvals result in a poor deal for both patients and cancer research.

While regulators claim they approve major advances, independent evidence documents flawed, biased, and incomplete evidence so that no one can know if most new drugs help cancer patients. Accelerated reviews and easy-ride quasi-evidence reward more research for more drugs with little evidence of benefit.